Author:
Stange D. E.,Weitz J.,Welsch T.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Al-Batran SE, Homann N, Schmalenberg H et al (2017) Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial. J Clin Oncol 35(suppl):abstr 4004
2. Biere SS, van Berge Henegouwen MI et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379(9829):1887–1892
3. Bozetti F, Marubini E, Bonfanti G et al (1999) Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 230(2):170
4. - (2017) Oesphagus including oesophagogastric junction. In: Brierley JD, Gospodarowicz MK, Wittekind C (Hrsg) TNM classification of malignant tumors, 8. Aufl. International Union Against Cancer, Oxford, S 57–62
5. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献